- €48.85m
- €51.75m
- €2.79m
Brief: Cube Labs H1 EBITDA €0.3 Mln
Brief: Cube Labs Says Insitutional Investor Completes Subscription Of 417,500 New Shares For EUR 1 Million
Brief: Cube Labs FY25 EBITDA At EUR 586,000
Brief: Cube Labs To Propose Capital Hike Up To EUR 15 Mln Within 5 Years
Brief: Cube Labs Unit DTECH Registers U.S. Patent
Brief: Cube Labs Unit Obtains Patent In India For Its Physiological Parameters Measuring System
Brief: Cube Labs Unit Rescue Code Granted European Patent For Surgical Device
Brief: Cube Labs Says Patent Request On Biodiapers Was Approved By European Patent Office
Brief: Cube Labs Unit Lipovexa Obtains U.S. Patent For New Therapeutic Platform For Treatment Of Metabolic Disorders
Brief: Cube Labs Renews Strategic Partnership With INBB
Brief: Cube Labs Concludes Capital Hike Option Offer, Shares Subscribed For EUR 0.4 Mln
Italy - Factors to watch on November 13
Italy - Factors to watch on November 13
Italy - Factors to watch on October 27
Brief: Cube Labs To Execute Capital Hike For Up To EUR 5 Mln
Brief: Cube Labs H1 Net Profit EUR 6.6 Mln
Brief: Cube Labs Establishes New Medtech Startup In Collaboration With Italy's IIT
Brief: Cube Labs Unit Wins €165,687 Grant To Develop Skin Medical Device
Brief: Cube Labs FY Net Loss EUR 0.7 Mln